CLC bio part of EU project aiming to diagnose genetic disorders using high-throughput sequencing

10-Dec-2009 - Denmark

Tthe EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project. The goal of the TECHGENE project is to incorporate the novel massively parallel sequencing technology in routine diagnostic laboratories for the improved diagnosis of genetically heterogeneous diseases. To do so, focus is on a number of model disorders that have shown different degrees of genetic complexity. Some of these model disorders selected are hemoglobinopathies, hereditary breast cancer, paraplegias, ataxias, mental retardation, and sensory disorders including blindness, deafness, and Usher syndrome.

Senior bioinformatics specialist at CLC bio, Patrick Dekker, PhD, states, "Being part of the TECHGENE project provides an excellent opportunity to developa solid solution for diagnostics using amplicon high throughput resequencing in conjuction with some of the most esteemed institutions.We look forward to providing the scientists involved with the ability todiagnose patients based on various chromosomal and gene regions, locate SNPs and Deletion/Insertion polymorphisms, copy number variations, among other things."

Other news from the department business & finance

These products might interest you

Limsophy

Limsophy by AAC Infotray

Optimise your laboratory processes with Limsophy LIMS

Seamless integration and process optimisation in laboratory data management

laboratory information management systems
ERP-Software GUS-OS Suite

ERP-Software GUS-OS Suite by GUS

Holistic ERP solution for companies in the process industry

Integrate all departments for seamless collaboration

software
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures